These results suggested, also in agreement with the available peer publications, that high TrkB-positivity might be indeed related with invasive tumor, and with therapy resistance [22] and with tumor cells with no apoptosis functionality (p53 altered). The gene discussed is TP53; the disease is neoplasm.